Introdução: As variações da CYP2D6 estão associadas com o desfecho clínico das pacientes na terapia adjuvante do câncer de mama com tamoxifeno (TAM). Esta associação deve-se principalmente a hidroxilação do N-desmetiltamoxifeno (NDT) pela CYP2D6 a endoxifeno (EDF) que, por sua alta potência antiestrogênica, é o principal responsável pela eficácia terapêutica. O objetivo deste estudo foi avaliar a relação entre o genótipo e o fenótipo da CYP2D6 com os níveis de EDF e a razão metabólica [NDT]/[EDF] em uma população do Sul do Brasil. Métodos: Foram obtidas amostras de plasma em vale de 97 pacientes em terapia com o tamoxifeno. A genotipagem da CYP2D6 foi realizada com ensaio Luminex, com determinação de escores de atividade genotípica (EAG). As concentrações do TAM e seus metabólitos foram determinados por CLAE-DAD e classificadas em metabolizadores lentos (ML), intermediários (MI), rápidos com atividade diminuída (MR-D), rápidos com atividade rápida (MR-R) e ultra-rápidos (UR). A fenotipagem foi realizada através da determinação do dextrometorfano (DMT) e do dextrorfano (DTF) por CLAE-FL nas amostras de plasma coletadas três horas após administração oral de 33 mg de DMT. A atividade da CYP2D6 foi avaliada pela razão metabólica [DMT]/[DTF]. Resultados: A genotipagem da CYP2D6 mostrou prevalência de 4,1% de ML, 4,1% de MI, 49,5% de MR-D, 39,2% de MR-R e 3,1% de UR. O genótipo (EAG) foi significativamente correlacionado com o fenótipo ([DMT]/[DTF]), com uma associação moderada (rs= -0,463; p<0,001). As medianas das concentrações plasmáticas do TAM e seus metabólitos (ng mL-1) foram: TAM 57,17; HTF 1,01; EDF 6,21; NDT 125,50. Os níveis de EDF foram inferiores nos ML em comparação aos MR (p<0,05). O fenótipo apresentou maior associação, porém ainda moderada, com os níveis de EDF e [NDT]/[EDF] em comparação ao genótipo (r= -0,507 r=0,625, p<0,001 versus r= 0,356 r=0,516; p<0,01). Ao fenótipo da CYP2D6 foram atribuídas 26% da variabilidade dos níveis de EDF e 38 % das razões metabólicas [NDT]/[EDF], enquanto que ao genótipo foram atribuídas 12% e 27 %, respectivamente. Conclusão: A genotipagem e/ou fenotipagem da CYP2D6 não foram capazes de predizer completamente as concentrações de EDF. Desta forma, sugerimos que estudos futuros utilizem o monitoramento dos níveis de EDF durante a terapia com TAM, com o objetivo de avaliar a sua efetividade. / Background: An association between CYP2D6 variation and clinical outcomes among women with breast cancer treated with tamoxifen (TAM) has been demonstrated, such that the presence of 2 functional CYP2D6 alleles was associated with better clinical outcomes. This association is mainly due the CYP2D6 mediated hydroxylation of N-desmethyltamoxifen (NDT) to yield endoxifen (EDF), which because of its high antiestrogenic potency, is the main responsible for the therapeutic efficacy of TAM. The aim of this study was to evaluate the relation of CYP2D6 genotyping and phenotyping with EDF levels and [NDT]/[EDF] metabolic ratio in breast cancer patients from South of Brazil under TAM therapy. Methods: Trough blood samples were collected from 97 patients. CYP2D6 genotyping was performed with a Luminex assay and calculation of Genotypic activity scores (GAS). Tamoxifen and metabolites EDF, NDT and 4-hidroxy-tamoxifen (HTF) were measured in plasma by HPLC-PDA. CYP2D6 phenotyping was performed by determination of dextromethorphan (DMT) and dextrorphan (DTF) by HPLC-FL at plasma collected three hours after oral administration of 33 mg of DMF. Phenotypes were given according to [DMT]/[DTF] metabolic ratio. Results: CYP2D6 genotyping indicated a prevalence of 4.1% PM, 4.1% IM, 49.5% EM-S, 39.2% EM-F and 3.1% UM. Genotype (GAS), was significantly correlated with phenotype ([DMT]/[DTF]), with a moderate association (rs= -0.463; p<0.001). Median plasma concentrations (ng mL-1) (N=97) were: TAM 57.17; HTF 1.01; EDF 6.21; NDT 125.50. EDF levels were lower in PM than in EM (p<0.05). Phenotype showed stronger, but still moderate, association with EDF and [NDT]/[EDF] than genotype (r= -0.507 r=0.625, p<0.001 versus r= 0,356 r=0.516, p<0.01). Phenotype accounted for 26% of the variability in EDF levels and 38 % of [NDT]/[EDF], while genotype for 12% and 27 %, respectively. Conclusion: CYP2D6 genotyping and/or phenotyping could not fully predict EDF concentrations. Monitoring EDF itself could be considered in further studies during TAM therapy in order to evaluate its efficacy

Across vertebrates, skeletal shapes are diverse, and much of this variation appears to be adaptive. In contrast, the early developmental programs of these structures are highly conserved across vertebrates. The question then becomes where in the conserved genetic programs of skeletal development does variation lie to direct diversity? In threespine stickleback, rapid changes in head and body shape have been documented during repeated and independent invasions of oceanic fish into freshwater habitats in regions deglaciated approximately 13,000 years ago. However, recent research indicates that similar phenotypic and genetic divergence can occur in decades. A remaining challenge is to link stickleback population genomic variation to causal genes that underlie such rapid phenotypic evolution. Here I use genome wide association studies (GWAS) in natural populations of stickleback to uncover genomic regions that contribute to variation of two dermal bone derived traits, lateral plate number and opercle shape. The decrease of lateral plate body armor and change in opercle bone shape, important for feeding mechanics, are classically associated with freshwater divergence. GWAS has recently begun to be used in natural populations but is still under scrutiny for performance among different populations. Using a population of phenotypically variable stickleback in Oregon, GWAS proved an effective method to uncover genomic regions and genetic variants known to contribute to lateral plate number and opercle shape, as well as new genomic regions and candidate genes not previously implicated in phenotypic variation. Although successful, using similar methods on decades old stickleback populations in Alaska revealed the challenges that accompany controlling population structure created by strong natural selection. Together, I found that although lateral plate number and opercle shape rapidly evolve in a coordinated fashion during adaptation from marine to freshwater environments, phenotypic variation is largely driven by independent genetic architectures. However, in very rapidly evolving populations, despite this independence of genetic architecture, the genetic variants contributing to the traits co-localize to similar genomic regions. This finding could be either biological or methodological which highlights the promise and limitations of using GWAS to identify genetic variation that gives rise to phenotypic diversity. This dissertation includes unpublished co-authored material.

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-08-30T20:49:47Z No. of bitstreams: 1 Tatiana Amorim Boa Sorte Estudo das bases moleculares da fenilcetonuria no nordeste do Brasil.pdf: 1805592 bytes, checksum: 2caa9f81224a65539eb11f580bd6b8a9 (MD5) / Made available in DSpace on 2012-08-30T20:49:47Z (GMT). No. of bitstreams: 1 Tatiana Amorim Boa Sorte Estudo das bases moleculares da fenilcetonuria no nordeste do Brasil.pdf: 1805592 bytes, checksum: 2caa9f81224a65539eb11f580bd6b8a9 (MD5) Previous issue date: 2010 / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil / As hiperfenilalaninemias (HPA), em especial a fenilcetonúria (PKU) estão entre os erros inatos do metabolismo mais bem estudados, por fazerem parte de programas de triagem neonatal em todo o mundo. No Brasil, o Programa Nacional de Triagem Neonatal (PNTN) garante o rastreamento, confirmação diagnóstica e tratamento desta condição em todo o país, através dos Serviços de Referência em Triagem Neonatal (SRTN). O PNTN oferece o diagnóstico bioquímico de PKU. A investigação molecular, através da detecção de mutações no gene da fenilalanina hidroxilase (PAH) não está prevista, e inexistem dados a este respeito na região nordeste do Brasil. O presente trabalho teve como objetivo caracterizar uma amostra de pacientes com HPA, quanto aos seus aspectos clínicos, demográficos, epidemiológicos e moleculares, além de avaliar a operacionalização do PNTN nesta região do país. MÉTODOS: Participaram do estudo pacientes da Bahia, Sergipe, Alagoas, Ceará, Maranhão e Piauí. Dados epidemiológicos e demográficos estiveram disponíveis apenas para pacientes da Bahia, e foram obtidos através de consulta a bancos de dados laboratoriais e prontuários médicos, nutricionais e sociais. Informações clínicas dos pacientes dos seis estados foram obtidas através de preenchimento de questionário. A Análise molecular incluiu investigação inicial para sete mutações no gene da PAH, previamente selecionadas (IVS10nt11ga, V388M, R261Q, R252W, I65T e R408W ) entre as mais frequentes em estudos brasileiros anteriores, através de RFLP, seguida de sequenciamento gênico dos éxons 3, 5, 6, 7, 11 e 12 do gene da PAH. Estudos de correlação genótipo-fenótipo foram realizados utilizando informações sobre atividade residual da PAH. RESULTADOS: Entre 1992 e 2009, foram diagnosticados 111 pacientes com HPA na Bahia. A cobertura populacional alcançou 90,81%, e a coleta do exame de triagem neonatal ocorreu após o 7º dia de vida em 76,8% dos casos, sendo a média da incidência de 1:16.362 NV. PKU clássica foi diagnosticada em 56,8% dos pacientes. A mediana de idade na primeira consulta foi de 34,5 dias para a PKU clássica nos últimos dois anos. A avaliação sócio econômica mostrou que 64,1% das genitoras não concluíram o ensino fundamental e 69,5% das famílias tinham renda abaixo de 2 salários mínimos. A partir de amostras de DNA de pacientes de seis estados do nordeste do Brasil, a triagem inicial de sete mutações permitiu a identificação de 64,3% dos genótipos. As mutações mais frequentes foram IVS10nt11ga (21,3%), V388M e I65T (15,8%) e R252W (14,6%). As menos frequentes foram R261Q (8,7%) e R408W (1,2%.). A mutação R261X não foi encontrada. Outras seis mutações foram identificadas através de sequenciamento gênico, com um total de 32 genótipos diferentes. Correlação entre genótipo e fenótipo apresentou-se adequada em 42,7% dos casos. A correlação foi mais evidente entre os pacientes com PKU leve ou moderada (68,2%) e genótipo homozigoto (45,4%). Mutações responsivas ao tratamento com tetrahidrobiopterina (V388M e I65T) foram encontradas com frequência relevante. CONCLUSÕES: Os dados epidemiológicos e clínicos serão de utilidade para a melhor organização das estratégias de saúde pública, enquanto que os dados moleculares poderão ser úteis em sugerir um painel de mutações mais adequado para investigação regional, ao tempo em que pode contribuir na otimização do tratamento e acompanhamento dos pacientes. / Hyperphenylalaninemia (HPA), especially phenylketonuria (PKU) are among the most studied inborn errors of metabolism, once they it is part of neonatal screening programs worldwide. In Brazil, National Neonatal Screening (PNTN) warrants screening, diagnostic confirmation and treatment of this condition across the country through the Reference Services for Neonatal Screening (SRTN). The PNTN offers biochemical diagnosis of PKU. Molecular investigation, by detecting mutations in the phenylalanine hydroxylase gene (PAH) is not provided, and there are no data so far in the northeast region of Brazil. This study aimed to characterize a sample of patients with HPA, in clinical, demographic, epidemiological and molecular aspects, and assess the implementation of PNTN at this region of the country. METHODS: Patients were from Bahia, Sergipe, Alagoas, Ceará, Maranhão and Piauí. Epidemiological and demographic data of patients were available only from Bahia, and were obtained by consulting the laboratory databases and medical, nutritional and social records. Clinical information of patients from all six states were obtained through a questionnaire. Molecular analysis included search for seven mutations in the PAH, previously selected (IVS10nt11g  a, V388M, R261Q, R252W, R408W and I65T) among the most frequent in previous Brazilian studies, using RFLP, followed by gene sequencing for éxons 3, 5, 6, 7, 11 and 12 of PAH gene. Studies of genotype-phenotype correlation were carried out using information on residual activity of PAH. RESULTS: Between 1992 and 2009, 111 patients were diagnosed with PAH in Bahia. The population coverage has reached 90.81% and the collection of samples for neonatal screening occurred after the 7th day of life in 76.8% of cases. The average incidence was 1:16.362 newborns. Classical PKU was diagnosed in 56.8% of patients. The median age at first visit was 34,5 days for classical PKU. Socioeconomic evaluation showed that 64.1% of mothers have not completed elementary education and 69.5% of households had income below two minimum wages. Using samples from six states of northeast of Brasil, screening for seven mutations allowed identification of, 64.3% of genotypes. By his screening, the most frequent mutations were IVS10nt11g  a (21.3%), I65T and V388M (15.8%) and R252W (14.6%). R261Q (8.7%) and R408W (1.2%) were less frequent. R261X was not found. Six other mutations have been identified through gene sequencing, with a total of 32 different genotypes. Correlation between genotype and phenotype presented adequate in 42,7% of cases. The correlation was most evident among patients with mild or moderate PKU (68,2%) and homozygous (45.4%). Mutations responsive to treatment with tetrahydrobiopterin (I65T and V388M) were found with significant frequency. CONCLUSIONS: The epidemiological and clinical data will be useful for better organization of public health strategies, whereas molecular data may be useful in suggesting a panel of mutations most appropriate for regional research at the time that may contribute to the optimization of treatment and monitoring of patients.

The PIK3R1 gene encodes three proteins - p85$\alpha$, p50$\alpha$ and p55$\alpha$ - that are regulatory subunits of Class IA phosphoinositide 3-kinases (PI3Ks). These regulatory subunits heterodimerise with one of three catalytic subunit isoforms, namely p110$\alpha$, p110$\beta$, or p110$\delta$. Class IA PI3Ks are critical enzymes involved in fundamental metabolic and mitogenic signalling pathways. This thesis describes the delineation of biochemical and molecular mechanisms whereby PIK3R1 mutations cause diverse disease phenotypes observed in SHORT syndrome (defined by Short stature, Hyperextensibility, Ocular depression, Rieger anomaly and Teething delay), the primary immunodeficiency Activated PI3K-$\delta$ Syndrome 2 (APDS2), and cancer. Initial studies of purified wildtype or mutant PI3K complexes, utilising a modified PI3K fluorescence polarisation lipid kinase assay, established that SHORT syndrome-associated p85$\alpha$ mutations impaired phosphotyrosine peptide-stimulated PI3K activity when heterodimerised with either of the Class IA catalytic subunit isoforms. Two cancer-associated mutations assessed using the same assay demonstrated differential effects on PI3K function, causing either basal activation or impaired phosphotyrosine peptide-stimulated PI3K activity. To examine the effect of SHORT syndrome-associated p85$\alpha$ mutations in insulin-responsive cell types, 3T3-L1 preadipocyte models with conditional overexpression of p85$\alpha$ Y657X or p85$\alpha$ R649W were generated. Doxycycline-induced overexpression of mutant p85$\alpha$ attenuated insulin-stimulated Akt phosphorylation due to reduced insulin-stimulated association of p85$\alpha$/p110$\alpha$ heterodimers with either IRS1 or IRS2. This in turn resulted in impaired downstream signalling as indicated by low adipogenic efficiency. Cells and tissues isolated from Pik3r1$^{WT/Y657X}$ knock-in mice also demonstrated decreased insulin-stimulated Akt phosphorylation. Observations from a system with endogenous expression of mutant p85$\alpha$ Y657X supported the results obtained in the 3T3-L1 p85$\alpha$ overexpression models. The final part of this thesis focussed on a PIK3R1 exon skipping mutant (p85$\alpha$ $\Delta$Ex11) that confers PI3K activation in lymphocytes and causes APDS2. APDS2 patients have an immune-restricted phenotype, even though the mutation occurs within the ubiquitously expressed PIK3R1. To investigate this phenomenon, the doxycycline-inducible system was used to model overexpression of p85$\alpha$ $\Delta$Ex11, as well as an activating p110$\alpha$ H1047R mutation associated with cancer, in 3T3-L1 preadipocytes. Surprisingly, given that APDS2 is not normally associated with metabolic or growth problems, high overexpression of p85$\alpha$ $\Delta$Ex11 severely attenuated insulin-stimulated Akt phosphorylation and adipocyte differentiation. There was also reduced insulin-stimulated recruitment of p110$\alpha$ to either IRS1 or IRS2, and impaired heterodimerisation of p85$\alpha$ $\Delta$Ex11 with p110$\alpha$. Collectively, the data presented in this thesis contributes to the developing knowledge of PIK3R1-related diseases. In particular, these studies provided novel insights into the biochemical and molecular mechanisms of SHORT syndrome-associated p85$\alpha$ mutations. Additionally, these data delivered further understanding of potential mechanisms underlying the immune-specific phenotype of APDS2 caused by PIK3R1 mutations.

O autismo apresenta uma alta herdabilidade e uma etiologia heterogênea, com o provável envolvimento de vários genes. Estudos recentes sugerem que características presentes nos pais de crianças com autismo apresentam paralelo com as apresentações de traços associados nos filhos. Este estudo avaliou 15 famílias de autistas, de Porto Alegre e região metropolitana, e controles. Foram utilizados quatro instrumentos de avaliação no estudo: dois avaliando as características nos filhos (ADI-R e Protocolo de Bosa) e dois aplicados aos pais (ITC e EDS). Os resultados deste estudo apontaram para a confirmação da agregação familiar de características fenotípicas herdadas independentemente. Apesar de diferirem dos resultados dos controles (pais de crianças com desenvolvimento típico), não comprovou-se a existência de uma diferença significativa na severidade de apresentações fenotípicas em pais de crianças autistas. Foi possível estabelecer a presença de uma configuração de características fenotípicas ligadas a aspectos do autismo em pais e crianças com autismo. Esta pesquisa aponta pistas para a existência de um padrão de herança dentro das famílias autistas. / The autism is a neuropsychiatric disturbance characterized by a retard pattern and by deficits in the development of the social abilities, of communication and by a restricted repertory of activities and interests. The beginning of this disturbance occurs at the first years of life. The autism presents a high inheritability and a heterogeneous etiology, with the probable involvement of several genes. Recent studies suggest that present characteristics in the parents of children with autism present parallel with the presentations of associated features in the children. This study evaluated 15 families of autists, from Porto Alegre and metropolitan region and controls. Four evaluation instruments was utilized in the study: two of them evaluating the characteristics in the children (ADI-R and Bosa's Protocol) and two of them applied to the parents (TCI and SAD). The results of this study pointed to the confirmation of the familiar aggregation of independently inherited phenotypical characteristics. Albeit they differ from the controls results (parents of children with typical development), it was not possible to prove the existence of a significative difference in the severity of phenotypical presentations in parents of autistic children. It was possible to establish a presence of a configuration of phenotypical characteristics connected to autism aspects in parents and children with autism. This research indicates clues for the existence of a inheritance pattern within the autistic families.

abstract: Rapid advancements in genomic technologies have increased our understanding of rare human disease. Generation of multiple types of biological data including genetic variation from genome or exome, expression from transcriptome, methylation patterns from epigenome, protein complexity from proteome and metabolite information from metabolome is feasible. "Omics" tools provide comprehensive view into biological mechanisms that impact disease trait and risk. In spite of available data types and ability to collect them simultaneously from patients, researchers still rely on their independent analysis. Combining information from multiple biological data can reduce missing information, increase confidence in single data findings, and provide a more complete view of genotype-phenotype correlations. Although rare disease genetics has been greatly improved by exome sequencing, a substantial portion of clinical patients remain undiagnosed. Multiple frameworks for integrative analysis of genomic and transcriptomic data are presented with focus on identifying functional genetic variations in patients with undiagnosed, rare childhood conditions. Direct quantitation of X inactivation ratio was developed from genomic and transcriptomic data using allele specific expression and segregation analysis to determine magnitude and inheritance mode of X inactivation. This approach was applied in two families revealing non-random X inactivation in female patients. Expression based analysis of X inactivation showed high correlation with standard clinical assay. These findings improved understanding of molecular mechanisms underlying X-linked disorders. In addition multivariate outlier analysis of gene and exon level data from RNA-seq using Mahalanobis distance, and its integration of distance scores with genomic data found genotype-phenotype correlations in variant prioritization process in 25 families. Mahalanobis distance scores revealed variants with large transcriptional impact in patients. In this dataset, frameshift variants were more likely result in outlier expression signatures than other types of functional variants. Integration of outlier estimates with genetic variants corroborated previously identified, presumed causal variants and highlighted new candidate in previously un-diagnosed case. Integrative genomic approaches in easily attainable tissue will facilitate the search for biomarkers that impact disease trait, uncover pharmacogenomics targets, provide novel insight into molecular underpinnings of un-characterized conditions, and help improve analytical approaches that use large datasets. / Dissertation/Thesis / Doctoral Dissertation Molecular and Cellular Biology 2015

Introdução: A rigidez arterial é um fenômeno complexo caracterizado pela diminuição da complacência vascular frente aos estímulos fisiológicos e patológicos. Semelhantemente a outros fenótipos cardiovasculares, a etiologia da rigidez arterial é modulada por fatores ambientais e genéticos. Levando em consideração a moderada herdabilidade e a característica poligênica do presente fenótipo, torna-se interessante a investigação de marcadores genéticos referentes aos diferentes sistemas envolvidos no remodelamento vascular. Objetivo: Avaliar o impacto dos polimorfismos C242T da subunidade p22phox da NADPH oxidase, G1036C da TXNIP, C609T/T471C da APOE, G1355A da elastina, I/D da ECA e A855G da MMP-9 no fenótipo de rigidez arterial em uma população geral. Métodos: Participaram do estudo 1.663 indivíduos da população geral da cidade de Vitória-ES. O DNA foi extraído a partir de uma amostra de sangue venoso. Posteriormente foram realizadas as genotipagens para as variantes genéticas supracitadas. A rigidez arterial foi avaliada por meio do método da velocidade de onda de pulso (VOP). Resultados: Em relação à VOP, os polimorfismos C242T da subunidade p22phox da NADPH oxidase e G1036C da TXNIP foram signifcativamente associados. Os indivíduos portadores do genótipo TT do polimorfismo C242T da subunidade p22phox (CC+TC=9,8 m/s versus TT=10,1 m/s, p=0,02) e do alelo G do polimorfismo G1036C da TXNIP (CC=9,8 m/s versus CG+GG=10,0 m/s, p=0,03) apresentaram maiores valores da VOP. Entretanto os polimorfismos C609T/T471C da APOE (2=10,0 m/s, 3=9,8 m/s, 4=9,8 m/s, p=0,60), G1355A da elastina (AA=9,8 m/s, GA=9,9 m/s, GG=9,8 m/s, p=0,92), I/D da ECA (DD=9,8 m/s, DI=9,8 m/s, II=9,9 m/s, p=0,53) e A855G da MMP-9 (AA=9,8 m/s, GA=9,8 m/s, GG= 9,8 m/s, p=0,60) não demonstraram tal associação. Somente o genótipo TT do polimorfismo C242T da subunidade p22phox (OR=1,93, p=0,002) apresentou um risco significativamente aumentado para o fenótipo de rigidez arterial. Já os polimorfismos G1036C da TXNIP (OR=1,19, p=0,19), C609T/T471C da APOE (OR=1,14, p=0,33), G1355A da elastina (OR=0,81, p=0,28), I/D da ECA (OR=0,91, p=0,48) e A855G da MMP-9 (OR=1,01, p=0,95) não apresentaram risco. Conclusão: Os polimorfismos C242T da subunidade p22phox da NADPH oxidase e G1036C da TXNIP podem contribuir como moduladores genéticos no enrijecimento vascular / Introduction: Arterial stiffness is a complex phenomenon characterized by decreased vascular compliance during physiological and pathological stimuli. Similar to other cardiovascular phenotypes, arterial stiffness etiology is modulated by environmental and genetic factors. Considering the moderate heritability and its polygenic phenotype, genetic markers investigations related to different systems involved in vascular remodeling are interesting. Objectives: To assess the impact of the p22phox C242T, TXNIP G1036C, APOE C609T/T471C, elastin G1355A, ACE I/D and MMP-9 A855G polymorphisms on arterial stiffness phenotype in a general population. Methods: This study included 1,663 individuals of the general population from Vitória-ES. DNA was extracted from a venous blood sample and genotyping assays were performed for the genetic variants described above. Arterial stiffness was evaluated by pulse wave velocity (PWV). Results: Regarding PWV, p22phox C242T and TXNIP G1036C polymorphisms were significantly associated. Individuals carrying TT genotype of the p22phox C242T (CC + CT vs TT = 9.8 m/s = 10.1 m/s, p = 0.02) and individuals carrying G allele of the TXNIP G1036C polymorphisms (CG + CC = 9.8 m/s vs GG = 10.0 m/s, p = 0.03) had higher PWV values. However, APOE C609T/T471C (2=10.0 m/s, 3=9.8 m/s, 4=9.8 m/s, p=0.60), elastin G1355A (AA=9.8 m/s, GA=9.9 m/s, GG=9.8 m/s, p=0.92), ACE I/D (DD=9.8 m/s, DI=9.8 m/s, II=9.9 m/s, p=0.53) and MMP-9 A855G (AA=9.8 m/s, GA=9.8 m/s, GG= 9.8 m/s, p=0.60) polymorphisms did not present association. Only the TT genotype of the p22phox C242T polymorphism (OR = 1.93, p = 0.002) presented an increased risk for the arterial stiffness phenotype. Already TXNIP G1036C (OR=1.19, p=0.19), APOE C609T/T471C (OR=1.14, p=0.33), elastin G1355A (OR=0.81, p=0.28), ACE I/D (OR=0.91, p=0.48) and MMP-9 A855G (OR=1.01, p=0.95) polymorphisms did not present risk. Conclusion: The p22phox C242T and the TXNIP G1036C polymorphisms may contribute to genetic modulators in vascular stiffening

Submitted by Camilla de Souza Nogueira (camilla.snogueira@hotmail.com) on 2017-04-13T20:48:51Z No. of bitstreams: 1 Dissertação_Camilla_de_Souza_Nogueira.pdf: 1143218 bytes, checksum: 572de02b17f467258e157b0bd4dfb1e8 (MD5) / Approved for entry into archive by Luiz Galeffi (luizgaleffi@gmail.com) on 2017-04-18T14:21:38Z (GMT) No. of bitstreams: 1 nogueira_cs_me_jabo.pdf: 1143218 bytes, checksum: 572de02b17f467258e157b0bd4dfb1e8 (MD5) / Made available in DSpace on 2017-04-18T14:21:38Z (GMT). No. of bitstreams: 1 nogueira_cs_me_jabo.pdf: 1143218 bytes, checksum: 572de02b17f467258e157b0bd4dfb1e8 (MD5) Previous issue date: 2017-03-20 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / A produção de carne no Brasil cresce constantemente, assim como as exigências do mercado e dos consumidores, que fazem a pecuária de corte estar sempre em busca de estratégias tecnológicas e de manejo para garantir maior retorno econômico da atividade. Aliado ao melhoramento genético, o uso da inseminação artificial em tempo fixo (IATF) ganha destaque na produção comercial. O objetivo deste estudo foi comparar grupos de progênies oriundas de IATF e de monta natural (MN), a fim de avaliar o impacto da tecnologia reprodutiva no peso a desmama (PD), ganho de peso pós-desmama (GPD), perímetro escrotal (PE) e musculatura (MUS), além de verificar a idade ao primeiro parto (IPP) e tempo de permanência (TP) das fêmeas em rebanhos Nelore criados em sistema extensivo. Os dados avaliados foram provenientes de seis fazendas participantes do programa de melhoramento genético Nelore Qualitas, utilizou-se registro de 65.086 animais. Análises estatísticas dos dados foram realizadas pelo procedimento GLM e as médias ajustadas foram comparadas entre os grupos, G_MN (grupo de progênies oriundas de MN) e G_IA (grupo de progênies oriundas de inseminação artificial), a partir do teste de Tukey-Kramer no programa SAS. A concentração de nascimentos, em ambos os grupos, ocorreu entre agosto e novembro, período com maior oferta de pastagem, o que resultou maior potencial de desempenho das progênies ao desmame. Os touros apresentaram papel fundamental no desempenho das progênies, sendo aquelas oriundas de IA mais eficientes (p<0,001) nas características estudadas. Os fenótipos do grupo G_IA para PD, GPD, PE e MUS foram 187,02 kg, 81,69 kg, 24,09 cm e 3,92, respectivamente, e com valores genéticos iguais a 4,64 kg, 7,48 kg, 0,49 cm e 0,23, respectivamente. Estes resultados apresentaram fenótipos e valores genéticos superiores (p<0,001) aos do grupo G_MN, 180,8 kg, 69,81 kg, 23,68 cm e 3,78 e 0,04 kg, 0,05 kg, -0,01 cm e 0,02, respectivamente. A tendência genética para as características avaliadas apresentaram-se positivas em ambos os grupos, porém com superioridade ao grupo G_IA, indicando a importância do uso de biotecnologia reprodutiva nos rebanhos a fim de garantir aumento do mérito genético dos animais e maior retorno econômico da atividade para os produtores. Para IPP, as fêmeas mais precoces foram do grupo G_MN, sugerindo falta de correlação genética com as características presentes no índice de seleção e que o uso de IATF não interfere na precocidade. O contrário acontece com a característica TP, a qual apresentou maior resultado em fêmeas do grupo G_IA, sugerindo maior retorno econômico da atividade em rebanhos que utilizam biotecnologia reprodutiva. A rentabilidade econômica apresentou-se eficiente com a utilização de IATF nos rebanhos estudados. / Meat production in Brazil is constantly growing, as well as the requirements of the market and consumers, which makes the making beef cattle to be always in search of technological strategies and management to ensure greater economic return to activity. Allied to genetic breeding, the use of fixed-time artificial insemination (FTAI) acquires emphasis in commercial production. The aim of this study was to compare progeny groups of FTAI and natural breeding (NB), in order to evaluate the reproductive technology impact in weaning weight (WW), postweaning weight gain (PWG), scrotal perimeter (SP) and musculature (MUS), besides checking the age at first calving (AFC) and time of permanency (TP) of females of Nelore herd created in extensive system. The data evaluated came from six farms that participate in the Nelore Qualitas breeding program, and it was used a register of 65,086 animals. Statistical analyzes of the data were performed by the GLM procedure and the adjusted means were compared between the groups, G_MN (group of progenies born by NB) and G_IA (group of progenies born by TFAI), by the Tukey-Kramer test in the SAS program. The concentration of births in both groups occurred between August and November, a period with greater pasture supply, which resulted in progeny’s greater performance potential at weaning. The bulls presented a fundamental role in the progeny performance, and those from AI were more efficient (p<0.001) in the studied traits. The phenotypes of the G_IA group for WW, PWG, SP and MUS were 187.02 kg, 81.69 kg, 24.09 cm e 3.92, respectively, and with genetic values equal to 4.64 kg, 7.48 kg, 0.49 cm e 0.23, respectively. These results showed phenotypes and higher genetic values (p <0.001) than those of the G_MN group, 180.8 kg, 69.81 kg, 23.68 cm and 3.78 and 0.04 kg, 0.05 kg, -0.01 cm and 0.02, respectively. The genetic tendency for the characteristics evaluated were positive in both groups, but superior in the G_IA group, which shows the importance of the reproductive biotechnology’s use in the herds, in order to guarantee the increase of the animals’ genetic merit and a greater economic return of the activities to the producers. For AFC, the earliest females were from the G_MN group, which suggest a lack of genetic correlation of the characteristics present in the selection index, and that the use of IATF does not interfere the precocity. The opposite occurs with the TP, which presented higher results in females of the G_IA group, and suggests a greater economic return of the activity in herds that use reproductive biotechnology. The economic profitability was efficient with the use of FTAI in the herds studied.

Made available in DSpace on 2014-12-17T14:13:26Z (GMT). No. of bitstreams: 1 SuzetATC.pdf: 3564049 bytes, checksum: 6d7a0053fa2fa8402dc4e922eb9cf43e (MD5) Previous issue date: 2009-04-07 / Objective: Identify phenotype and genotype parameters of female volleyball players at different performance levels to help in player selection. Methods: We identified characteristics of phenotype and genotype using the somatotype method (Heath Carter); anthropometry (weight, height and fat percentage); dermatoglyphics (Cummins and Midlo s method) as well as applying physical quality tests (Shuttle Run to assess agility and the Sargent Jump Test adapted for spike and block reach). The sample was composed of 179 players (54 from national teams and 125 from state teams). Results: Somatotype was similar among the performance levels in the mesomorphic component. The Height and ectomorphic component were greater in national team players as was spike and block reach. The vertical jump height for the spike was similar between the national under-17 team and the state teams observed, but in the block jump the lower level players were better. The dermatoglyphics characteristics identified were similar among the groups studied. Conclusions: The results of the variables studied show that somatotype, height, spike reach and block reach are fundamental parameters in player selection and in the specific characteristics of each game position of this sport. This paper proposes a multidisciplinary approach applicable in the fields of physical education, medicine and nutrition / Objetivo: Identificar par?metros fenot?picos e genot?picos de atletas de voleibol feminino no Brasil, em diferentes n?veis de qualifica??o esportiva, que auxiliar?o no processo de sele??o de atletas. M?todos: Identificamos as caracter?sticas fenot?picas e genot?picas atrav?s da Somatotipia (m?todo de Heath Carter); da antropometria (peso, estatura e percentual de gordura); da dermatoglifia (m?todo de Cummins e Midlo) e de testes de qualidades f?sicas (Shutle Run para verificar a agilidade e Sargent Jump Test adaptado para alcance de ataque e de bloqueio). A amostra foi composta de 179 atletas sendo 54 de sele??es nacionais e 125 de sele??es estaduais. Resultados: O somatotipo apresentou-se como vari?vel equilibrada entre os diferentes n?veis de qualifica??o esportiva no componente mesom?rfico. A estatura e o componente ectom?rfico foram superiores nas atletas das sele??es nacionais assim como o alcance de ataque e de bloqueio. A altura do salto vertical para o ataque foi equilibrado entre a sele??o nacional infanto-juvenil e as sele??es estaduais observadas, mas no salto para bloqueio as atletas de mais baixo n?vel de qualifica??o esportiva foram superiores. As caracter?sticas dermatogl?ficas identificadas demonstraram um equil?brio entre os grupos estudados. Conclus?es: Diante das vari?veis estudadas pode-se concluir que o somatotipo, a estatura, o alcance de ataque e o alcance de bloqueio s?o par?metros fundamentais na sele??o de atletas e nas caracter?sticas espec?ficas de cada posi??o de jogo, nessa modalidade. Esta tese apresenta uma rela??o de interface multidisciplinar, tendo o seu conte?do uma aplica??o nos campos da Educa??o F?sica, medicina e nutri??o

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Different forms of isolated GH deficiency (IGHD) have an autosomal recessive mode of inheritance. The most common one (type IB) is often caused by bi-allelic mutations in the GHRH receptor (GHRHR) gene (GHRHR). Although heterozygous carriers of GHRHR mutations appear normal, the small size of most of the families and the fact that stature is a complex and polygenic trait prevented so far a careful analysis of their phenotype. To test the hypothesis that heterozygosity for a GHRHR mutation may be associated with a mild phenotype, we studied large Brazilian kindred with familial IGHD (Itabaianinha cohort). In this population, GHD is caused by a homozygous null mutation of the GHRHR. Adults and children with GHD have severe short stature, reduced lean mass, increased % fat mass, increased waist to hip (W/H) ratio, increased total and LDL-cholesterol and C-reactive protein (CRPus), increased systolic blood pressure, and increased insulin sensitivity. We studied 77 adult subjects (age 25-75) heterozygous for the mutation (WT/MT) and compared them with age and sex-matched controls homozygous for the wild-type allele (WT/WT) from the same population. Genotyping was performed by denaturing gradient gel electrophoresis from genomic DNA. We found no difference in adult height; blood pressure and standard deviation score for serum IGF-I between the two groups. Body weight, body mass index, skin folds, waist, hip, lean and fat mass were all reduced in WT/MT subjects. %FM and W/P ratio were similar in the two groups. Fasting insulin and in HOMAIR were lower in WT/M than in WT/WT. The other biochemical parameters (total and fractionated cholesterol, triglycerides, Lp (a), CRPus) were not different between the two groups. Our data shows that heterozygosity for a null GHRHR mutation is not associated with reduction in adult stature or reduction in serum IGF-I, but it causes a parallel decline in fat and lean mass, and an increase in insulin sensitivity. Heterozygosis for a null GHRHR mutation is not associated with reduction in adult stature or in serum IGF-I, but is causes changes in body composition and increase in HOMAIR. These effects do not seem to be modulated by changes circulating IGF-I. / Diferentes formas de Deficiência Isolada do Hormônio do Crescimento (DIGH) são de herança autossômica recessiva. A mais comum (tipo IB) é freqüentemente causada por mutações bi-alélicas no gene do receptor de GHRH (GHRHR). Embora portadores heterozigotos da mutação do gene do GHRHR pareçam normais, o tamanho pequeno da maior parte das famílias e o fato que a estatura é um complexo determinado por características poligênicas levaram-nos a analisar cuidadosamente a hipótese de um fenótipo para a heterozigose. Para testar a hipótese de que a heterozigose para uma mutação do GHRHR poderia estar associado a um fenótipo intermediário foi estudada uma extensa família com DIGH familial (Coorte de Itabaianinha/Sergipe). Nesta população a DIGH é causada por uma mutação nula em homozigose do gene do receptor do GHRHR. Os adultos e crianças com DIGH têm severa baixa estatura, massa magra reduzida e aumento de: percentagem (%) de massa gorda (% MG), cintura, relação cintura/quadril, Colesterol total, LDL Colesterol, Proteína C Reativa alta sensibilidade (PCRas) e a diminuição do Modelo Homeostático do Índice de Resistência à Insulina (HOMAIR). Nós estudamos 76 indivíduos adultos entre 25 e 75 anos de idade heterozigotos (WT/MT) para esta mutação e comparamos pareados para a idade e sexo com 77 indivíduos controles homozigotos para o alelo normal (WT/WT) da mesma população. O DNA genômico foi genotipado através da técnica de Eletroforese em gel com gradiente de desnaturação (DGGE). Não foi encontrada nenhuma diferença entre os indivíduos na altura dos adultos e níveis séricos de IGF-I entre os dois grupos. O peso, o índice de massa corpórea (IMC), dobras cutâneas, circunferência da cintura e quadril e massa magra (MM) estavam reduzidos no grupo de indivíduos WT/MT. A % de MG e a relação cintura/quadril foram semelhantes entre os dois grupos. A insulina e o HOMAIR foram mais baixos no grupo WT/MT. Os outros parâmetros bioquímicos (colesterol total e frações, Triglicérides, Lipoproteína (a) (LP (a)), Proteína C Reativa alta sensibilidade (PCRas) não foram diferentes entre os dois grupos. Em conclusão, a heterozigose para uma mutação nula no gene do receptor do GHRH não é associada com redução da estatura final nem nos níveis séricos de IGF-I, mas, causa alterações na composição corporal e aumento do HOMAIR. Estes efeitos parecem não ser modulados por alterações nas concentrações séricas de IGF-I).